Health Movers: Teva Pharmaceutical Industries (NYSE:TEVA), Amarin Corporation (NASDAQ:AMRN), Endo Health Solutions (NASDAQ:ENDP), Allergan (NYSE:AGN)

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) could soon be without the services of its billionaire chairman Philip Frost if reports appearing on the media are true. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) stock opened at $48.32 in last session, and closed at $49.29, while the day range of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) stock is $48.02 – $49.40. The stock showed a positive weekly performance of 2.26%.

Amarin Corporation plc (ADR) (NASDAQ:AMRN) a late stage biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced financial results for the quarter and year ended December 31, 2013, and provided an update on company operations. Amarin Corporation plc (ADR) (NASDAQ:AMRN) stock opened at $1.76 in last session, and closed at $1.78 by losing -0.56%. The 52 week range of $1.36 – $8.77. Company’s market capitalization is $302.93M.

Endo Health Solutions Inc. (NASDAQ:ENDP) announced that Ivan P. Gergel, executive vice president research & development and chief scientific officer, will be leaving the Company. Endo Health Solutions Inc. (NASDAQ:ENDP) stock increased 2.72% and finished the last session at $81.49. The EPS of the stock remained -5.58. Company’s market capitalization is $9.32B.

Allergan, Inc. (NYSE:AGN) will begin trading ex-dividend on February 26, 2014. A cash dividend payment of $0.05 per share is scheduled to be paid on March 21, 2014. Allergan, Inc. (NYSE:AGN) stock opened the session at $126.39, and closed the session at $128.55. The 52 week range of the Allergan, Inc. (NYSE:AGN) stock remained $81.33 – $128.61 and the day range was $126.02 – $128.61.